Vesalius Therapeutics Funding: $75M Raised, Series A (2022)

Vesalius Therapeutics is based in Cambridge, MA. It has raised $75M in total funding. Latest round: Series A. Backed by Flagship Ventures, Polaris Partners.

Vesalius Therapeutics funding overview

Vesalius Therapeutics is based in Cambridge, MA. Vesalius Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Vesalius Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Flagship Ventures, Polaris Partners. 2 distinct backers are named across the disclosed rounds.

Vesalius Therapeutics at a glance

Total raised
$75M
Latest round
Series A
Latest round date
March 2022
Headquarters
Cambridge, MA
Notable investors
Flagship Ventures, Polaris Partners

Frequently asked about Vesalius Therapeutics funding

How much has Vesalius Therapeutics raised?
Vesalius Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Vesalius Therapeutics?
Flagship Ventures, Polaris Partners are named among the investors backing Vesalius Therapeutics.
What was the latest Vesalius Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2022.
Where is Vesalius Therapeutics based?
Vesalius Therapeutics is based in Cambridge, MA.
When did Vesalius Therapeutics last raise?
The last disclosed Vesalius Therapeutics round closed in March 2022 at Series A.

Every Vesalius Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to Vesalius Therapeutics (23)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026